Search for: "Barr v. State"
Results 881 - 900
of 1,075
Sorted by Relevance
|
Sort by Date
28 Jul 2023, 11:49 am
Barr ,1 illustrates the problem. [read post]
1 Dec 2019, 7:09 am
That he has gotten away with this for such a long time is all the more astounding considering that his boss, Attorney General William Barr, once testified against Qualcomm and its business practices.As I just said, each of those many pro-FTC submissions serves a purpose. [read post]
25 Jun 2024, 1:29 pm
United States v. [read post]
26 Nov 2023, 7:06 am
To be sure, in a series of cases staring with the Delaware Supreme Court’s 2019 decision in Marchand v. [read post]
29 Sep 2009, 11:38 am
We noted in Cross v. [read post]
8 Nov 2021, 12:25 pm
Barr, No. 19-cv-1581, 2019 WL 2870234, at *2 (D.D.C. [read post]
8 Nov 2021, 12:25 pm
Barr, No. 19-cv-1581, 2019 WL 2870234, at *2 (D.D.C. [read post]
31 Aug 2021, 7:34 am
Sasse to Attorney General Barr (Aug. 13, 2019). [read post]
27 Aug 2011, 7:55 pm
Barr Labs., Inc., 575 F.3d 1341, 1350 (Fed. [read post]
30 Jul 2023, 11:24 am
See United States v. [read post]
18 Oct 2019, 12:56 pm
Finally, in Lomax v. [read post]
29 Mar 2019, 1:49 pm
In Texas v. [read post]
7 Jun 2010, 9:36 am
Related posts:Prosecution Laches and Inequitable Conduct: Cancer Research Tech. v Barr Labs. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
27 May 2008, 6:41 am
Barr Labs., Inc., 251 F.3d 955, 963 (Fed. [read post]
8 Dec 2010, 10:42 am
Inc. v. [read post]
23 May 2019, 7:08 am
The analysis is lengthy, so I will state my main conclusions here: None of the critics defends the report’s actual reasoning, which is pretty obviously flawed. [read post]
8 Feb 2008, 7:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Record labels sue Baidu over providing links to file-sharing sites: (Ars Technica), (Techdirt), (Out-Law), (IP Law360), (Copyfight), Merck’s Fosamax patent expires: Watson Pharmaceuticals to distribute authorized generic version, Teva and Barr also launch FDA approved generic versions: (SmartBrief), (Patent Circle),… [read post]
25 Mar 2011, 8:29 pm
Barr Labs., Inc., 251 F.3d 955, 962 (Fed. [read post]
